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OBJECTIVES: Few studies have evaluated cardiac electrical activation dynamics after cardiac resynchronization
therapy. Although this procedure reduces morbidity and mortality in heart failure patients, many approaches
attempting to identify the responders have shown that 30% of patients do not attain clinical or functional
improvement. This study sought to quantify and characterize the effect of resynchronization therapy on the
ventricular electrical activation of patients using body surface potential mapping, a noninvasive tool.
METHODS: This retrospective study included 91 resynchronization patients with a mean age of 61 years, left
ventricle ejection fraction of 28%, mean QRS duration of 182 ms, and functional class III/IV (78%/22%); the
patients underwent 87-lead body surface mapping with the resynchronization device on and off. Thirty-six
patients were excluded. Body surface isochronal maps produced 87 maximal/mean global ventricular activation
times with three regions identified. The regional activation times for right and left ventricles and their inter-
regional right-to-left ventricle gradients were calculated from these results and analyzed. The Mann-Whitney
U-test and Kruskall-Wallis test were used for comparisons, with the level of significance set at p#0.05.
RESULTS: During intrinsic rhythms, regional ventricular activation times were significantly different (54.5 ms vs.
95.9 ms in the right and left ventricle regions, respectively). Regarding cardiac resynchronization, the maximal
global value was significantly reduced (138 ms to 131 ms), and a downward variation of 19.4% in regional-left
and an upward variation of 44.8% in regional-right ventricular activation times resulted in a significantly
reduced inter-regional gradient (43.8 ms to 17 ms).
CONCLUSIONS: Body surface potential mapping in resynchronization patients yielded electrical ventricular
activation times for two cardiac regions with significantly decreased global and regional-left values but
significantly increased regional-right values, thus showing an attenuated inter-regional gradient after the
cardiac resynchronization therapy.
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& INTRODUCTION
Heart failure (HF) has become a major health problem
worldwide, and its incidence has increased over the last 60
years (1-3). This increase can be largely attributed to an
aging population and longer survival rates for patients
because of novel treatment strategies, which have resulted
in increased hospitalizations for HF patients (1-4). Cardiac
resynchronization therapy (CRT), one of the non-pharma-
cological approaches, has been responsible not only for
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significant improvement in patient quality of life but also for
the decrease in mortality among these patients (5-10).
In spite of the favorable and clearly reproducible results
of CRT, 20 to 30% of patients (i.e., the so-called non-
responders) show no improvement either clinically or
functionally following treatment (11-12).
Different echocardiographic variables have been studied
(12-14) in an attempt to identify these non-responders, and
these studies have initially yielded promising results.
However, the poor sensitivity and specificity for all
variables in these studies negated the prospect of using
these measures of dyssynchrony to select patients for CRT
(13-14). A comprehensive evaluation of the role played by
electrocardiography in CRT had similarly inconclusive
results (15). Furthermore, one previous electrophysiological
study using electro-anatomical mapping found great varia-
bility in the electrical and hemodynamic variables (16).
Other investigators have used information extracted from
electrodes inserted into the ventricles (during and after
CRT) in an attempt to correlate the electrical data with both
hemodynamic information and the clinical evolution of
patients (17-19).
In addition, studies using different approaches in
individuals with either left or right bundle-branch block
have elucidated the behavior of cardiac electrical phenom-
ena (20-22). Medvegy et al. elegantly summarized the
resources offered by body surface potential mapping
(BSPM) and its potential application by suggesting that
Selvester diagrams be used for an anatomical distribution of
electrodes on the body surface (23).
Despite the results of many studies reporting data from
patients with resynchronization devices, researchers world-
wide continue to search for a method that could determine
which patients would respond better to CRT. Such a method
should be simple, quick, reproducible, easily performed,
pose low risk to patients, and of high accuracy.
Our study is part of a line of investigation that began in
the mid-1990s when BSPM was first employed to study
patients with left bundle-branch blocks (LBBB) (20) and was
later used to study the effects of CRT in those patients. The
initial study conducted by Pastore et al. (24), which
analyzed BSPM findings with a clinically oriented inter-
pretation of BSPM data from a population of patients
who had undergone CRT, reported gradients of regional
activation. Moreover, the BSPM methodology has emerged
as an alternative, noninvasive approach for studies inves-
tigating cardiac activation (24,25).
The present study was designed to quantify and obtain
detailed characterization of the effect of CRT on ventricular
electrical activation in patients with congestive heart failure
using the noninvasive BSPM methodology.
& MATERIAL AND METHODS
Study population
We conducted a retrospective study of noninvasive BSPM
performed in 91 non-consecutive patients who had under-
gone CRT. BSPMs were performed in two settings: 1) after
CRT implantation and 2) with the device turned off in
native sinus rhythm + LBBB. The two BSPM examinations
were performed within a maximum interval of 300 days
(median time, 98 days). The final population included 55
patients, after 36 patients were excluded (exclusion criteria
below).
Inclusion criteria – Patients adhering to the Artificial
Pacing Unit of the Heart Institute (InCor) after undergoing
CRT with the classic indications for therapy (i.e., sinus
rhythm, LBBB, depressed left ventricle ejection fraction
[LVEF], New York Heart Association functional class III/IV,
and routine use of medications for HF) were included.
Exclusion criteria – Patients with atrial fibrillation (n = 20),
and/or those dependent on a permanent pacemaker prior to
CRT (n = 9), and/or with right bundle-branch block (RBBB,
n = 3), and/or a diagnosis of hypertrophic (n = 3) and/or
congenital cardiopathy (n = 1) were excluded.
This study complied with the Declaration of Helsinki and
was approved by the Institutional Review Board of the
Heart Institute (InCor-HC-FMUSP).
Body surface potential mapping (BSPM)
The 87 unipolar electrodes of the Fukuda Denshi model
7100 BSPM equipment (Fukuda Denshi Co., Ltd., Tokyo,
Japan) were attached to adhesive strips, distributed over the
anterior chest (59 leads) and back (28 leads), and recorded
simultaneously. Electrical potentials were digitized, pro-
cessed, and visualized at the BSPM matrix as PQRST
complexes distributed according to the lead system orienta-
tion. The potentials were also indexed using letters and
numbers, with each strip corresponding to a letter (A
through I on the chest and J through M on the back) and
numbers one to seven corresponding to the lines) (Figure 1).
This system was used to assess traditional electrovector-
cardiographic variables (i.e., the rhythm, PR interval, axes,
QRS complex width, and orientation and direction of loops
in the horizontal and frontal planes). Additionally, this
software enables the acquisition of other cardiac electrical
data, such as a map of the isochronal lines and ventricular
activation times, as described below.
The isochronal lines of activation provided by the body
surface potential mapping are based on the QRS complex
duration values. During the process of electrocardiographic
data acquisition, one of the QRS complexes is selected to
guide the acquisition of the QRS complex durations in all 87
leads. By positioning the two cursors available on the
display, one at the onset and the other at the end of the
chosen QRS complex in each lead, these measurements are
semi-automatically performed. Then, it is possible to
quantify the QRS complex width for all 87 leads. With
these point-by-point measurements, the entire electrical
process of the QRS complex can be studied. If we assume
that the QRS complex duration is obtained, it is then
possible to interpret the meaning of such values as the
quantification of the ventricular electrical activation. Thus,
the analysis of the 87 QRS complex duration values enables
the temporal visualization of the path that an electrical
stimulus has travelled through the ventricles, and it is also
possible to identify the leads in which the QRS complex was
generated the fastest and slowest.
Based on the values obtained from our patients, and using
the data defined by the Selvester diagrams reported by
Medvegy et al. (23), we identified three distinct areas by
comparing the activation time values from the 87 leads.
First, we noticed that the first four electrode strips (A to D)
displayed a similar pattern, the second set of four strips (E
to H) showed another pattern, and the third set of four
strips (I to L) showed a third pattern, thereby demonstrating
separation into three different areas with distinct mean
activation times. By comparing the results from the QRS
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duration obtained from the 87 leads in our study with the
knowledge of a typical LBBB activation pattern, we could
associate these three distinct areas with the right ventricle
(RV) region, an intermediate region, and the left ventricle
(LV) region (Figure 1).
Therefore, the moments in which the different regions
within the myocardium were activated could be character-
ized, which meant that we were able to observe and
regionalize the ventricular electrical activation process.
Because the intermediate region identified may comprise
areas that relate to the right ventricle and other areas that
relate to the left ventricle, we decided to measure and analyze
only two regions: those with electrical characteristics that are
typical of the right ventricle or the left ventricle.
Global and regional ventricular activation time (VAT)
values and inter-regional gradients were calculated accord-
ing to the BSPM maps, first during biventricular pacing
with CRT on and then in the intrinsic rhythm (sinus rhythm
+ LBBB) with the resynchronization device off.
The maximal global VAT was collected based on the maximal
values obtained in the 87 leads, and mean global VAT was
obtained by calculating the arithmetical average of all 87 values.
Second, we measured the regional ventricular activation
times, which were calculated based on the VAT values in the
regions described above. The VAT mean values for the right
ventricle (RV) and left ventricle (LV) regions were obtained
by arithmetically averaging the VAT values from the 26 leads
apportioned to the RV region and the VAT values from the 26
leads apportioned to the LV region (Figure 1).
The inter-regional gradients were calculated based on the
difference between the regional mean RV and LV values
described above.
These three sets of variables allowed us to better
characterize the global, regional, and inter-regional behavior
of the ventricular electrical activation sequence during both
the intrinsic rhythm (sinus rhythm + LBBB) and atrio-
biventricular (BIV) pacing.
After obtaining these measures, we were able to analyze
the impact of CRT on ventricular electrical activation by
calculating the percentage of variation in the VAT values.
This measurement revealed the changes promoted by CRT
and was calculated as follows:
variation = {[VAT in BIV pacing]-[VAT in sinus
rhythm+LBBB]}6 [100]/[VAT in sinus rhythm+LBBB].
Figure 1 - Distribution of the 87 electrodes on the anterior chest and back, which were indexed by letters (strips or columns) and
numbers (lines), and their regional distribution. Three distinct areas (denominated right ventricle region, an intermediate region, and
left ventricle region) could be identified based on the three different mean activation patterns shown by each set of four strips of
electrodes (i.e., A to D, E to H, and I to L, see details in the Methods section).
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This calculation was performed for the global and
regional values and the inter-regional gradients.
Statistical analysis
Because some of the data showed a non-Gaussian or
skewed distribution, we chose to express the continuous
variables as medians with the respective maximum and
minimum values. Categorical variables were expressed as
percentages. Global, regional, and inter-regional VATs were
compared using the nonparametric Mann-Whitney U-test
and the Kruskal-Wallis test. The level of significance was
established at p#0.05.
& RESULTS
The following clinical characteristics were observed for
the 55 patients included in this study: mean age, 61¡10
years; 60% (n = 33) male; etiology of HF as predominantly
idiopathic (51%, n = 28), ischemic (20%, n = 11), chagasic
(14.5%, n = 8), or hypertensive (14.5%, n = 8); mean left
ventricle ejection fraction, 0.28¡0.09; mean QRS duration,
182¡24 ms; and New York Heart Association functional
class III (78%, n = 43) and IV (22%, n = 12).
Table 1 displays the ventricular electrical activation
development (in ms) for the two settings with and without
CRT action (medians and max-min values). The effect of
CRT is shown in terms of variation in the study variables
and the respective significance level.
The maximal global VAT in sinus rhythm+LBBB was
prolonged (138 ms) in comparison to the CRT-on situation
(131 ms). However, the mean global VAT showed the
opposite trend, with a nearly 10% increase during biven-
tricular pacing (64.8 ms vs. 70.5 ms).
An analysis of the regional ventricular electrical activation
revealed significant differences between the two areas
during the intrinsic rhythm. There was also a considerable
delay between the activations of the LV and RV regions
(95.9 ms vs. 54.5 ms, p,0.001). During CRT, these differ-
ences were less pronounced, with an increased RV (78.9 ms)
and decreased LV regional value (77.3 ms) (Figure 2). In
addition, note that we observed almost simultaneous
activation of the RV and LV regions during CRT.
Inter-regional relationships during intrinsic rhythm+LBBB
showed significant delay between the LV-RV regions
(43.8 ms) (p,0.001), which were attenuated by CRT. The
analysis of inter-regional gradients characterized this phe-
nomenon by showing significantly reduced LV-RV delay
(17.0 ms) (Figure 3).
Finally, the results of the percentage variation highlighted
the impact of CRT on ventricular electrical activation, as we
found that the maximal global VAT was reduced by 5.1%,
but the mean global VAT was increased by 8.8% with CRT.
Furthermore, the regional analysis showed that the CRT
effect increased the VAT value of the RV region by 44.8%,
while the VAT of the LV region was decreased by 19.4%
(Figure 4). Consequently, we observed a significant reduc-
tion (61.2%) in the inter-regional LV-RV gradient (Figure 5).
& DISCUSSION
Many studies have been conducted to better understand
the cardiac electromechanical phenomenon in patients
indicated for CRT, with the goal of reducing the number
of non-responders.
In the present study, we quantitatively characterized the
ventricular electrical activation in a patient population
implanted with CRT. Therefore, we analyzed the global
and regional ventricular activation times as well as the inter-
regional gradients. In addition, we obtained the measure-
ments for the percentage variation in the VAT values, which
enabled us to better understand how CRT works from an
electrical perspective.
During intrinsic rhythm+LBBB, we were able to quantify the
significantly increased (80%) regional-LV VAT value. Thus,
we observed a prolonged inter-regional LV-RV gradient.
Therefore, BSPM could assess the typical electrocardio-
graphic presentation of an LBBB conduction disorder,
which, according to our findings, demonstrated a maximal
global ventricular activation time .120 ms, a mean global
VAT .60 ms, and a greater regional-LV VAT value
compared to the regional-RV VAT value.
Two studies investigating the electrical activation of
individuals with LBBB used electro anatomical mapping
for such characterizations (21,22). Using a different metho-
dology may explain why these studies were unable to
provide a clear discrimination or quantification of the time
when activation occurs in the right ventricle, intermediate,
and left ventricle regions. The relationships between those
Table 1 - Ventricular electrical activation development (in milliseconds).
Sinus rhythm + LBBB Biventricular Pacing Variation p-value
Median Min-Max Median Min-Max
Maximal Global VAT 138 106-139 131 60-225 Q5.1% 0.007
Mean Global VAT 64.8 48.1-87.8 70.5 25.3-98.2 q8.8% ns
RV Regional VAT 54.5 21.7-86.9 78.9 20.0-126.5 q44.8% 0.001
LV Regional VAT 95.9 47.3-123.4 77.3 21.9-119.2 Q19.4% 0.001
Inter-regional LV-RV gradients 43.8 0.08-96.00 17.0 0.38-46.12 Q61.2% 0.001
LBBB= left bundle-branch block; LV= left ventricle; ns=not significant; RV= right ventricle; VAT= ventricular activation time.
Figure 2 - Comparison of regional RV and regional LV activation
times during sinus rhythm and biventricular pacing.
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regions were also unclear, as both studies showed sig-
nificantly delayed activation of the LV in relation to that of
the RV, ranging from 89 ms to 110 ms, which agrees with
the value described and quantified in our study. In addition,
the study by Fantoni et al. (22) was the only one in which a
mean activation time of 75 ms could be inferred for the RV,
which aligned with our results.
Regarding biventricular pacing, we were able to quantify
values for the global and regional VATs and inter-regional
gradients, which may facilitate understanding of the
electrical phenomena that occur during CRT.
A significant reduction in the maximal global VAT to
131 ms was observed when the resynchronization device
was on, albeit with a slight rise in the mean global VAT to
70.5 ms. This global VAT behavior can likely be fully
explained by the changes that occur in regional VATs
during biventricular pacing. In addition, under CRT, the
regional-LV VAT was shortened by nearly 20%. Note that
under the influence of LBBB, the maximal global VAT
reflects the extremely long activation times in the left
ventricle; therefore, the decrease in regional-LV VAT during
CRT was associated with the concomitant decrease in
maximal global VAT. However, we observed that the
regional-RV VAT was nearly 45% further delayed during
biventricular pacing. The increase in mean regional-RV VAT
greatly surpassed the amount by which the regional-LV
VAT was reduced, which indicates that the increase in mean
global VAT during biventricular pacing reflects this
phenomenon. Moreover, the goal of CRT (i.e., restoring
the ventricular mechanics and reestablishing synchroniza-
tion of the ventricles) allows better understanding of these
electrical phenomena. Moreover, this synchrony (or dyssyn-
chrony) can be better evaluated according to the temporal
relationships between the ventricular regions (inter-regional
gradients).
Contrary to what we found during sinus rhythm+LBBB,
biventricular pacing led to a significant 61.2% reduction in the
interventricular delay, which we termed the inter-regional LV-
RV gradient. This reduction provides evidence that under CRT,
the time of LV activation approaches that of RV activation.
Varma et al. (25) showed that CRT led to activation times
of 63.0 ms and 83.5 ms for the RV and LV, respectively,
which were similar to those reported in the present study.
Varma et al. also reported a clear change in activation of
both the RV (increasing from 37 ms to 63 ms) and LV
(decreasing from 113 ms to 83.5 ms) after resynchroniza-
tion, and these values were also quite similar to those
observed in our study. Furthermore, both in this previous
study and in our study, the RV ventricular activation time
approached that of LV. Pratola et al. (16), who found a total
activation time of 68.5 ms during biventricular pacing,
which aligned with our mean global VAT value of
70.5 ms. In 2010, Sassone et al. (19) reported a measurement
termed RVLV interlead electrical delay, which represented
the time difference between intracavitary electrograms
obtained from the right ventricle lead in relation to the left
ventricle lead at the end of the resynchronization device
implantation. Although these authors used a distinct
methodology, their results were similar to our inter-regional
LV-RV gradient. After a six-month follow-up period, these
authors also found a significantly reduced value in the
responder group (22.1 ms vs. 43.6 ms). In our study, the
inter-regional LV-RV gradient of 17 ms obtained during
biventricular pacing may be used to guide the placement of
ventricular electrodes to adjust the interventricular pacing
delay and help identify the individuals who will receive the
most benefit from CRT.
We calculated the VAT variation to assess the behavior of
ventricular activation times during CRT. This measurement
quantifies the CRT effect upon the ventricular electrical
activation process, which shortened the time difference
between activation of the left and right ventricles.
The above results indicate that, from the electrical
standpoint, CRT attempted to restore the coupling of the
ventricles in the hearts, which did not occur under LBBB.
This coupling was enabled by the simultaneous anticipation
of LV activation and the delay of RV activation. We believe
these findings are of the utmost importance because it was
possible to quantitatively demonstrate in detail the altera-
tions that occur with global, regional, and inter-regional
Figure 3 - Inter-regional LV-RV gradients in sinus rhythm and
biventricular pacing.
Figure 4 - Regional VAT variation for the RV (increased) and LV
(decreased).
Figure 5 - The inter-regional LV-RV gradient variation showed a
significant reduction.
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ventricular activation when the resynchronization device is
operating. These data (regional-RV VAT and variation of
mean global VAT) may further serve as the basis for future
studies involving CRT and its clinical outcomes.
Study limitations
This was a retrospective study in which we used very strict
exclusion criteria (40% of patients excluded) to obtain
maximal homogeneity in the patient sample, and this
resulted in a drastic reduction in the number of individuals
included in the study population (only 55 patients). Other
potential factors may have interfered with our results, such as
the timing of the BSPM examinations, which varied from 120
to 300 days after CRT in 95% of the sample, and the lack of
data concerning the localization of electrodes implanted in
the left ventricle, a factor considered by some authors to be of
some importance. Furthermore, new developments in drug
therapy may have had implications on cardiac remodeling as
well. As a retrospective study, we were unable to perform
body surface mapping prior to implantation of the resyn-
chronization device. We are also aware that we may have
analyzed data from patients who had already undergone
some cardiac remodeling; however, our results showed that
there was a difference in activation when the devices were
not operating. We can, therefore, infer that the differences we
found would be even greater had we measured the cardiac
electrical activation prior to implantation. Thus, this factor
likely does not invalidate our findings and rather indicates
that the study outcomes may be underestimated.
Analysis of the ventricular activation times obtained by
body surface potential mapping enabled characterization of
the ventricular electrical activation phenomenon in patients
undergoing cardiac resynchronization therapy. Our results
indicated that CRT led to a maximal global reduction by 5.1%
and similar regional ventricular activation times in the two
ventricular regions studied (78.9 ms and 77.3 ms for the RV
and LV regions, respectively), which resulted in enhanced
synchronization of the ventricles according to the significant
61.2% reduction in the inter-regional LV-RV gradient.
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